Differential effects of interferon alpha-2b and beta on the signaling pathways in human liver cancer cells

Journal of Gastroenterology

Volumn 40, Issue 7, 2005, Pages 722-732

  Matsumoto, Kazuya ^a   Okano, Jun Ichi ^a   Murawaki, Yoshikazu ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

AKT; Extracellular signal regulated kinase; Interferon 2b; Interferon ; Liver cancer

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALPHA2C INTERFERON; BETA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MITOSIS INHIBITION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON ALFA-2B; INTERFERON-BETA; LIVER NEOPLASMS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; PROBABILITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 25144507653     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-005-1616-x     Document Type: Article

References (44)

1. JM Kirkwood MS Ernstoff 1984 Interferons in the treatment of human cancer J Clin Oncol 2 336-52 6323641
2. S Nishiguchi S Shiomi S Nakatani T Takeda K Fukuda A Tamori et al. 2001 Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis Lancet 357 196-7 10.1016/S0140-6736(00)03595-9 11213099
3. A Kasahara N Hayashi K Mochizuki M Takayanagi K Yoshioka S Kakumu et al. 1998 Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C Hepatology 27 1394-402 10.1002/hep.510270529 9581697
4. K Ikeda Y Arase S Saitoh M Kobayashi Y Suzuki F Suzuki et al. 2000 Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor. A prospective randomized study of hepatitis C virus-related liver cancer Hepatology 32 228-32 10.1053/jhep.2000.9409 10915728
5. T Suou A Mitsuda M Koda H Matsuda S Maruyama H Tanaka et al. 2001 Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: A pilot study Hepatol Res 20 301-11 10.1016/S1386-6346(00)00148-0 11404190
6. CL Lai JY Lau PC Wu H Ngan HT Chung SJ Mitchell et al. 1993 Recombinant interferon-alpha in inoperable hepatocellular carcinoma: A randomized controlled trial Hepatology 17 389-94 10.1016/0270-9139(93)90049-S 8383088
7. JM Llovet M Sala L Castells Y Suarez R Vilana L Bianchi et al. 2000 Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma Hepatology 31 54-8 10.1002/hep.510310111 10613728
8. H Yano A Iemura M Haramaki S Ogasawara A Takayama J Akiba et al. 1999 Interferon alpha receptor expression and growth inhibition by interferon alpha in human liver cancer cell lines Hepatology 29 1708-17 10.1002/ hep.510290624 10347112
9. D Murphy KM Detjen M Welzel B Wiedenmann S Rosewicz 2001 Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases Hepatology 33 346-56 10.1053/jhep.2001.21749 11172336
10. A Obora Y Shiratori M Okuno S Adachi Y Takano R Matsushima-Nishiwaki et al. 2002 Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cells Hepatology 36 1115-24 10.1053/jhep.2002.36369 12395321
11. SJ Grille A Bellacosa J Upson AJ Klein-Szanto F van Roy W Lee-Kwon et al. 2003 The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines Cancer Res 63 2172-8 12727836
12. JT Fassett D Tobolt CJ Nelsen JH Albrecht LK Hansen 2003 The role of collagen structure in mitogen stimulation of ERK, cyclin D1 expression, and G1-S progression in rat hepatocytes J Biol Chem 278 31691-700 10.1074/jbc.M300899200 12794085
13. L Gong Y Li A Nedeljkovic-Kurepa FH Sarkar 2003 Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells Oncogene 22 4702-9 10.1038/sj.onc.1206583 12879015
14. M Bustos N Beraza JJ Lasarte E Baixeras P Alzuguren T Bordet et al. 2003 Protection against liver damage by cardiotrophin-1: A hepatocyte survival factor up-regulated in the regenerating liver in rats Gastroenterology 125 192-201 10.1016/S0016-5085(03)00698-X 12851883
15. Y Agazie I Ischenko M Hayman 2002 Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene Oncogene 21 697-707 10.1038/ sj.onc.1205115 11850798
16. JS Sebolt-Leopold 2000 Development of anticancer drugs targeting the MAP kinase pathway Oncogene 19 6594-9 10.1038/sj.onc.1204083 11426644
17. J Okano AK Rustgi 2001 Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery J Biol Chem 276 19555-64 10.1074/jbc.M011164200 11278851
18. Q Chen B Gong AS Mahmoud-Ahmed A Zhou ED Hsi M Hussein et al. 2001 Apo2L/ TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma Blood 98 2183-92 10.1182/blood.V98.7.2183 11568006
19. BH Morrison JA Bauer DV Kalvakolanu DJ Lindner 2001 Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells J Biol Chem 276 24965-70 10.1074/jbc.M101161200 11337497
20. T Hisaka H Yano S Ogasawara S Momosaki N Nishida Y Takemoto et al. 2004 Interferon-alphaCon1 suppresses proliferation of liver cancer cell lines in vitro and in vivo J Hepatol 41 782-9 10.1016/j.jhep.2004.07.012 15519651
21. A Budillon P Tagliaferri M Caraglia MR Torrisi N Normanno S Iacobelli et al. 1991 Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells Cancer Res 51 1294-9 1997168
22. IM Kerr AP Costa-Pereira BF Lillemeier B Strobl 2003 Of JAKs, STATs, blind watchmakers, jeeps and trains FEBS Lett 546 1-5 10.1016/ S0014-5793(03)00411-3 12829228
23. M Caraglia G Vitale M Marra A Budillon P Tagliaferri A Abbruzzese 2004 Alpha-interferon and its effects on signalling pathways within cells Curr Protein Pept Sci 5 475-85 10.2174/1389203043379378 15581417
24. W Jin L Wu K Liang B Liu Y Lu Z Fan 2003 Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells Br J Cancer 89 185-91 10.1038/sj.bjc.6601048 12838322
25. M de Lujan Alvarez JP Cerliani J Monti C Carnovale MT Ronco G Pisani et al. 2002 The in vivo apoptotic effect of interferon alpha-2b on rat preneoplastic liver involves Bax protein Hepatology 35 824-33 10.1053/ jhep.2002.32099 11915028
26. P Merle L Barraud L Lefrancois M Chevallier S Guerret M Maisonnas et al. 2003 Long-term high-dose interferon-alpha therapy delays Hepadnavirus-related hepatocarcinogenesis in X/myc transgenic mice Oncogene 22 2762-71 10.1038/sj.onc.1206375 12743599
27. A Takaoka S Hayakawa H Yanai D Stoiber H Negishi H Kikuchi et al. 2003 Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence Nature 424 516-23 10.1038/ nature01850 12872134
28. S Radaeva B Jaruga F Hong WH Kim S Fan H Cai et al. 2002 Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes Gastroenterology 122 1020-34 10.1053/ gast.2002.32388 11910354
29. V Giandomenico G Vaccari G Fiorucci Z Percario S Vannuchi P Matarrese et al. 1998 Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21 Eur Cytokine Netw 9 619-31 9889406
30. I Sakai K Takeuchi H Yamauchi H Narumi S Fujita 2002 Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells Blood 100 2926-31 10.1182/blood-2002-01-0073 12351404
31. O Sangfelt S Erickson J Castro T Heiden S Einhorn D Grander 1997 Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines Cell Growth Differ 8 343-52 9056677
32. J Brognard PA Dennis 2002 Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants Cell Death Differ 9 893-904 10.1038/sj.cdd.4401054 12181740
33. H Prietzsch J Brock HD Kleine S Liebe R Jaster 2002 Interferon-alpha inhibits cell cycle progression by Ba/F3 cells through the antagonisation of interleukin-3 effects on key regulators of G1/S transition Cell Signal 14 751-9 10.1016/S0898-6568(02)00023-2 12034356
34. WC Hung LY Chuang 1999 Sodium butyrate enhances STAT1 expression in PLC/ PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha Br J Cancer 80 705-10 10.1038/sj.bjc.6690413 10360647
35. T Arora G Floyd-Smith MJ Espy DF Jelinek 1999 Dissociation between IFN-alpha-induced anti-viral and growth signaling pathways J Immunol 162 3289-97 10092781
36. Y Tsukada K Miyazawa N Kitamura 2001 High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2 J Biol Chem 276 40968-76 10.1074/jbc.M010890200 11533045
37. Q Zeng S Chen Z You F Yang TE Carey D Saims et al. 2002 Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B J Biol Chem 277 25203-8 10.1074/jbc.M201598200 11994287
38. CH Yang A Murti SR Pfeffer JG Kim DB Donner LM Pfeffer 2001 Interferon alpha/beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt J Biol Chem 276 13756-61 11278812
39. O Barca S Ferre M Seoane JM Prieto M Lema R Senaris et al. 2003 Interferon beta promotes survival in primary astrocytes through phosphatidylinositol 3-kinase J Neuroimmunol 139 155-9 10.1016/ S0165-5728(03)00160-7 12799034
40. M David E Petricoin III C Benjamin R Pine MJ Weber AC Larner 1995 Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins Science 269 1721-3 7569900
41. JH Song EY So CE Lee 2002 Increased serine phosphorylation and activation of STAT1 by oncogenic Ras transfection Mol Cells 13 322-6 12018856
42. H Nguyen CV Ramana J Bayes GR Stark 2001 Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression J Biol Chem 276 33361-8 10.1074/jbc.M105070200 11438544
43. L Pelicano F Li C Schindler MK Chelbi-Alix 1997 Retinoic acid enhances the expression of interferon-induced proteins: Evidence for multiple mechanisms of action Oncogene 15 2349-59 10.1038/sj.onc.1201410 9393879
44. S Tedjarati CH Baker S Apte S Huang JK Wolf JJ Killion et al. 2002 Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel Clin Cancer Res 8 2413-22 12114447